Dean C. Kehler
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
NioCorp Signs Traxys Deal, Secures 100% of Elk Creek Output. NioCorp has placed 100% of its planned critical minerals production under commercial sales agreements, including a 15-year deal with Traxys. This move supports financing efforts for the Elk Creek project, which is also receiving attention from the U.S. Export-Import Bank. The stock is currently trading near its 52-week low, reflecting the ongoing uncertainty around project funding.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 1, 2026
Celularity Q1 2027 EPS Up, Announces Partner & Board Member. Celularity posted a first‑quarter 2027 earnings per share of $0.02, up from a loss of $0.84 a year earlier, while sales fell to $3.85 million from $11.43 million. The company will open the Fontaine Vitale facility with its strategic partner and added Naveen Jain to its board. It also closed a $10 million private placement of senior secured convertible notes and warrants, part of a $28 million recapitalization plan.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 30, 2026
El Pollo Loco Targets 15 New NY Restaurants by 2027. El Pollo Loco announced it is expanding into New York, with its first Queens location targeted for mid-2027. The company also signed agreements to open 15 restaurants over the next five years and updated its leadership team. These moves show a push for growth in a major new market, which is relevant as the stock trades near its 52-week low.
Transaction History
| BCIC | ▼ Sell | Open Market | 15,000 | $115K | 5/18/2026 | View on chart |
| BCIC | ▼ Sell | Open Market | 37,100 | $274K | 3/23/2026 | View on chart |
| BCIC | ▼ Sell | Open Market | 27,378 | $208K | 3/19/2026 | View on chart |
| BCIC | ▼ Sell | Open Market | 23,000 | $183K | 3/18/2026 | View on chart |
| BCIC | ▼ Sell | Open Market | 3,089 | $25K | 3/18/2026 | View on chart |
| BCIC | ▼ Sell | Open Market | 500 | $4K | 3/12/2026 | View on chart |
| BCIC | ▼ Sell | Open Market | 16,200 | $143K | 3/12/2026 | View on chart |
| BCIC | ▼ Sell | Open Market | 9,000 | $81K | 3/11/2026 | View on chart |
| BCIC | ▼ Sell | Open Market | 854 | $8K | 3/11/2026 | View on chart |
| BCIC | ▼ Sell | Open Market | 957 | $11K | 12/29/2025 | View on chart |
| BCIC | ▼ Sell | Open Market | 28,673 | $340K | 12/29/2025 | View on chart |
| NB | ▼ Sell | Other | 78,003 | $276K | 12/15/2025 | View on chart |
| CELU | ▲ Buy | Grant | 67,416 | $0 | 12/19/2024 | View on chart |
| NB | ▲ Buy | Open Market | 56,577 | — | 11/13/2024 | View on chart |
| NB | ▲ Buy | Open Market | 78,003 | — | 12/22/2023 | View on chart |
| CELU | ▲ Buy | Grant | 199,921 | $0 | 6/14/2023 | View on chart |
| LOCO | ▼ Sell | Other | 5,182,564 | $0 | 3/28/2023 | View on chart |
| LOCO | ▼ Sell | Other | 4,800,152 | $0 | 3/28/2023 | View on chart |
| LOCO | ▼ Sell | Other | 11,116,638 | $0 | 3/28/2023 | View on chart |
| CELU | ▲ Buy | Grant | 36,145 | $0 | 7/13/2022 | View on chart |
| LOCO | ▲ Buy | Grant | 5,693 | $0 | 5/10/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 9, 2026
BCIC Schedules Q3 2026 Earnings Release
BCP Investment Corporation announced the date for its third‑quarter 2026 earnings release and the accompanying conference call. The disclosure gives investors a timeline for upcoming financial results. The company currently trades with a trailing P/E of about 68 and a dividend yield above 15%, which may be considered when evaluating the forthcoming report.
BCIC Schedules Q3 2026 Earnings Release. BCP Investment Corporation announced the date for its third‑quarter 2026 earnings release and the accompanying conference call. The disclosure gives investors a timeline for upcoming financial results. The company currently trades with a trailing P/E of about 68 and a dividend yield above 15%, which may be considered when evaluating the forthcoming report.